Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-discovers-the-occurrence-of-gut-microbiome-dysbiosis-at-the-prodromal-stages-of-parkinson-s-disease-gives-novel-insights-into-neurodegenerative-prevention-intervention-and-diagnosis
https://www.med.cuhk.edu.hk/press-releases/cuhk-discovers-the-occurrence-of-gut-microbiome-dysbiosis-at-the-prodromal-stages-of-parkinson-s-disease-gives-novel-insights-into-neurodegenerative-prevention-intervention-and-diagnosis

CUHK discovers the occurrence of gut microbiome dysbiosis at the prodromal stages of Parkinson’s disease Gives novel insights into neurodegenerative prevention, intervention and diagnosis

Parkinson’s disease (PD) is the second most common neurodegenerative disease worldwide. Early intervention reduces symptoms’ impact on patients. A study conducted by The Chinese University of Hong Kong’s (CUHK) Faculty of Medicine (CU Medicine) discovered that patients with rapid eye movement sleep behaviour disorder (RBD), a sleep disorder common in patients at the prodromal stages of PD, suffer gut microbiome dysbiosis similar to that of PD patients. In addition, the research team found that similar changes in gut microbes have already emerged in first-degree relatives of RBD patients. Notably, the abundance of health-promoting bacteria is depleted in their gut, while pro-inflammatory bacteria that could potentially disrupt intestinal barrier integrity are enriched. 

 

Study results revealed that gut microbiome dysbiosis is a risk factor at the very early stage of PD, even occurring before the onset of RBD. This sheds light on the identification of high-risk prodromal PD cases by gut microbiome screening, as well as paving the way for early intervention, prevention and treatment of PD and other neurodegenerative diseases by targeting gut microbiome features. Study details have been published in the leading international journal Nature Communications.

 

Intestinal dysfunction may play a crucial role in early PD

 

In 2019, CU Medicine’s Department of Psychiatry conducted the world’s first in-person family RBD study. The study confirmed that first-degree relatives of RBD patients are three to six times of healthy controls to suffer from a series of neurodegenerative problems, including RBD, PD and dementia. Professor Liu Yaping, Adjunct Assistant Professor of the Department of Psychiatry at CU Medicine, said, “It is worth noting that relatives of RBD patients have a significantly higher incidence of constipation, suggesting that intestinal dysfunction may play a key role in the pathogenesis of early PD, which is worth further investigation.”

 

Professor Liu Yaping

Professor Liu Yaping states that first-degree relatives of RBD patients are three to six times of healthy controls to suffer from a series of neurodegenerative problems, including RBD, PD and dementia.

Professor Huang Bei

Professor Huang Bei explains that when the integrity of the intestinal barrier in PD patients is destroyed, it is easier for certain gut metabolites from the microbes and pro-inflammatory factors to enter the nervous system, triggering the abnormal aggregation of synuclein in the enteric nervous system and then progressing into central nervous system, finally leading to neuronal death. 

 

Interdisciplinary collaboration to understand the correlation between the microbiota-gut-brain axis and PD

To understand the correlation between the microbiota-gut-brain axis and the pathogenesis of PD, CU Medicine’s Department of Psychiatry, Department of Microbiology, Division of Neurology, Department of Anatomical and Cellular Pathology, Department of Surgery and Centre for Gut Microbiota Research, and the Center of Parkinsonism and Movement Disorders at the Paracelsus-Elena Hospital in Kassel, Germany, recruited 441 participants, including healthy individuals, RBD patients and their first-degree relatives, and patients with early PD. 

Surprisingly, gut microbiome dysbiosis was found in patients with RBD and also among their first-degree relatives, whose microbial compositions have become similar to those of PD patients. This included a depletion of health-promoting bacteria (such as Faecalibacterium and Roseburia) and an increase in bacteria that promote inflammation and disrupt intestinal barrier integrity (such as Collinsella and Akkermansia). These changes cannot be fully explained by constipation symptoms and medications in patients with PD and RBD.

Professor Huang Bei, Research Assistant Professor of CU Medicine’s Department of Psychiatry, explained, “Gut microbiota changes affect the health of both the gut and brain. When the integrity of the intestinal barrier in PD patients is destroyed, it is easier for certain gut metabolites from the microbes and pro-inflammatory factors to enter the nervous system, triggering the abnormal aggregation of synuclein (a neuronal protein) in the enteric nervous system and then progressing into central nervous system, finally leading to neuronal death. This reflects that gut microbiome dysbiosis may be a potential factor leading to Parkinson’s disease.”

Professor Wing Yun Kwok

Professor Wing Yun-kwok states that through the microbiota-gut-brain axis, the gut microbiome influences different physiological conditions such as our sleep, mood, memory and cognitive function. Restoring healthy gut microbiota, for example by alternating probiotics and prebiotics, would be an early intervention and method of prevention and treatment of PD and other synucelinopathy-related neurodegenerative diseases.

Microbial markers are effective in distinguishing RBD from control

 

Further analysis with machine learning found that 12 microbial markers could effectively distinguish RBD patients from healthy controls. This will facilitate screening of these gut microbial markers to allow early identification of patients with RBD at the prodromal stage of PD. This may reduce their chances of developing PD in the long run through early intervention.

 

Professor Wing Yun-kwok, Chairman of CU Medicine’s Department of Psychiatry, concluded, “Through the microbiota-gut-brain axis, the gut microbiome influences different physiological conditions such as our sleep, mood, memory and cognitive function. This interdisciplinary study further confirmed that before the onset of PD or even the occurrence of RBD, the patients’ gut ecosystem was disturbed. Restoring healthy gut microbiota, for example by alternating probiotics and prebiotics, may be an early intervention and method of prevention and treatment of PD and other synucelinopathy-related neurodegenerative diseases.”

 

The original study can be accessed here: https://doi.org/10.1038/s41467-023-38248-4.

 

Background information of Parkinson’s disease

 

There are currently about 12,000 PD sufferers in Hong Kong. Unfortunately, conventional treatment can only alleviate disease symptoms, and there is no cure at present. The natural history of the development of PD has become clearer and the onset of motor symptoms of PD is usually preceded by a prodromal stage of 10 to 20 years. During this period, half of the patients suffer from RBD. Because of a loss of muscle atonia that a healthy person is expected to have during rapid eye movement sleep (when dreaming occurs), RBD patients act out their dreams. These dream enactment behaviours consist of a constellation of features including shouting, punching, kicking, and rolling, leading to sleep-related violence and injuries. More importantly, studies have shown that more than 90% of RBD patients will go on to develop PD, and other synuceleinopathy-related neurodegenerative diseases within 15 years.

More Press Releases

CUHK Conducts World’s First Family Study on Rapid Eye Movement Sleep Behaviour Disorder to Investigate Familial Link with Parkinson’s Disease

CUHK Conducts World’s First Family Study on Rapid Eye Movement Sleep Behaviour Disorder to Investigate Familial Link with Parkinson’s Disease

Research
CUHK confirms depression sufferers with rapid eye movement sleep behaviour disorder harbour familial predisposition to neurodegeneration Provides new insights on improving precision psychiatry and preventing neurodegeneration

CUHK confirms depression sufferers with rapid eye movement sleep behaviour disorder harbour familial predisposition to neurodegeneration Provides new insights on improving precision psychiatry and preventing neurodegeneration

Research
Joint Study by CUHK and HKSH Reveals Patients with Comorbid REM Sleep Behavior Disorder and Depression may Suffer from Early-stage Neurodegeneration

Joint Study by CUHK and HKSH Reveals Patients with Comorbid REM Sleep Behavior Disorder and Depression may Suffer from Early-stage Neurodegeneration

Research
CU Medicine-developed app proves effective in assessing depression

CU Medicine-developed app proves effective in assessing depression

Research
CUHK launches the Jockey Club Sleep Well Project –  Hong Kong’s first large-scale community outreach programme to promote sleep health, using cognitive behavioural therapy to treat insomnia

CUHK launches the Jockey Club Sleep Well Project – Hong Kong’s first large-scale community outreach programme to promote sleep health, using cognitive behavioural therapy to treat insomnia

Health Campaign
CUHK-HKU-UL Conducts World’s First Insomnia Prevention Programme and Proves Insomnia is Preventable in At-risk Adolescents

CUHK-HKU-UL Conducts World’s First Insomnia Prevention Programme and Proves Insomnia is Preventable in At-risk Adolescents

Research
CUHK-HKU Study Proves Bright Light Therapy as an Adjunctive Treatment Improves Outcomes in Depressed “Night Owl” Patients

CUHK-HKU Study Proves Bright Light Therapy as an Adjunctive Treatment Improves Outcomes in Depressed “Night Owl” Patients

Research
Risk of Diabetes Patients Having Depression Doubles That of the General Public CUHK Advocates Timely Assessment of Diabetes Patients’ Mental Health Conditions

Risk of Diabetes Patients Having Depression Doubles That of the General Public CUHK Advocates Timely Assessment of Diabetes Patients’ Mental Health Conditions

Research
CUHK Pioneers Surgical Treatment of Deep Brain Stimulation for Tardive Dystonia in HK

CUHK Pioneers Surgical Treatment of Deep Brain Stimulation for Tardive Dystonia in HK

Surgical advancement
CUHK identifies novel gut microbiome biomarkers to facilitate diagnosis of autism spectrum disorders  Pilot clinical study shows modulation of gut microbiome alleviates anxiety symptoms

CUHK identifies novel gut microbiome biomarkers to facilitate diagnosis of autism spectrum disorders Pilot clinical study shows modulation of gut microbiome alleviates anxiety symptoms

Research
CUHK study reveals microbiota modulation is effective in alleviating insomnia

CUHK study reveals microbiota modulation is effective in alleviating insomnia

Research
CU Medicine study reveals increasing cognitive activity participation strengthens brain network

CU Medicine study reveals increasing cognitive activity participation strengthens brain network

Research
CUHK proves its self-developed oral microencapsulated live bacteria formula SIM03 improves disease severity and quality of life in children with eczema

CUHK proves its self-developed oral microencapsulated live bacteria formula SIM03 improves disease severity and quality of life in children with eczema

Research
CU Medicine study published in The Lancet Infectious Diseases concludes that a novel oral microencapsulated live bacteria consortia (SIM01) alleviates long COVID symptoms

CU Medicine study published in The Lancet Infectious Diseases concludes that a novel oral microencapsulated live bacteria consortia (SIM01) alleviates long COVID symptoms

Research
CUHK announces survey results on the mental health of local child, adolescent and elderly populations

CUHK announces survey results on the mental health of local child, adolescent and elderly populations

Research
CU Medicine develops novel microbiome technology MOZAIC for faecal microbiota transplantation; Enhancing treatment success for Clostridioides difficile infections to over 90%

CU Medicine develops novel microbiome technology MOZAIC for faecal microbiota transplantation; Enhancing treatment success for Clostridioides difficile infections to over 90%

Research
CU Medicine discovers gut microbiome and metabolome markers that predict long-term COVID-19 vaccine effectiveness

CU Medicine discovers gut microbiome and metabolome markers that predict long-term COVID-19 vaccine effectiveness

Research
A randomised placebo-controlled clinical trial by CU Medicine shows that modulation of gut microbiome using oral microencapsulated live bacteria (SIM01) improves long COVID symptoms

A randomised placebo-controlled clinical trial by CU Medicine shows that modulation of gut microbiome using oral microencapsulated live bacteria (SIM01) improves long COVID symptoms

Research
CUHK supports World Sleep Day 2023 Calls for attention to adverse effects of sleep problems, including increased risk of long COVID, mental and cardiovascular problems

CUHK supports World Sleep Day 2023 Calls for attention to adverse effects of sleep problems, including increased risk of long COVID, mental and cardiovascular problems

Research
CU Medicine, MagIC and HKSTP join hands to organise the Microbiome Summit 2023 “Hong Kong as a regional hub for microbiome industry”

CU Medicine, MagIC and HKSTP join hands to organise the Microbiome Summit 2023 “Hong Kong as a regional hub for microbiome industry”

Symposium
CUHK conducts interdisciplinary study on gut microbiota in pregnancy to reduce risk of inflammatory bowel disease in babies

CUHK conducts interdisciplinary study on gut microbiota in pregnancy to reduce risk of inflammatory bowel disease in babies

Research
Large-scale clinical study shows CU Medicine (SIM01) microbiome formula reduces risk of infections including COVID-19

Large-scale clinical study shows CU Medicine (SIM01) microbiome formula reduces risk of infections including COVID-19

Research
CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long COVID

CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long COVID

Research
Joint CUHK-HKU study discovers efficacy of COVID-19 vaccines correlates with a probiotic bacterium, Bifidobacterium adolescentis

Joint CUHK-HKU study discovers efficacy of COVID-19 vaccines correlates with a probiotic bacterium, Bifidobacterium adolescentis

Research
CUHK Discovers Children with Autism Have Delayed Gut Microbiome Maturity and  Identifies Faecal Bacterial Markers for Autism

CUHK Discovers Children with Autism Have Delayed Gut Microbiome Maturity and Identifies Faecal Bacterial Markers for Autism

Research
CUHK Develops a Novel Faecal Test that can Detect Polyps and Early Colon Cancers  with Sensitivity Over 90%

CUHK Develops a Novel Faecal Test that can Detect Polyps and Early Colon Cancers with Sensitivity Over 90%

Research
CU Medicine Study Shows Modulation of Gut Microbiota  Helps Enhance Safety and Efficacy of COVID-19 Vaccine

CU Medicine Study Shows Modulation of Gut Microbiota Helps Enhance Safety and Efficacy of COVID-19 Vaccine

Research
CU Medicine Receives USD 2 Million from The Helmsley Charitable Trust to Partner with University of Calgary to Create a Global Repository on the Epidemiology of Crohn's Disease

CU Medicine Receives USD 2 Million from The Helmsley Charitable Trust to Partner with University of Calgary to Create a Global Repository on the Epidemiology of Crohn's Disease

Research
CU Medicine Finds New Evidence for Link between Gut Microbiome and COVID-19 Severity Microbiome Imbalance Might Influence “Long COVID” Risk

CU Medicine Finds New Evidence for Link between Gut Microbiome and COVID-19 Severity Microbiome Imbalance Might Influence “Long COVID” Risk

Research
40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

Research
Most Deaths from COVID-19 in Hong Kong are of 60 Years Old or Above CUHK Initiated International Effort in Devising Strategies to Protect Older People with Dementia amid COVID-19 Pandemic

Most Deaths from COVID-19 in Hong Kong are of 60 Years Old or Above CUHK Initiated International Effort in Devising Strategies to Protect Older People with Dementia amid COVID-19 Pandemic

Research
CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

Research
The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

Research
CUHK Survey Reveals Majority of School Teens Have Insufficient Sleep

CUHK Survey Reveals Majority of School Teens Have Insufficient Sleep

Health Campaign
CUHK Research Indicates Acupuncture can Improve Cognitive Functions of Elderly - More Elderly Participants to be Recruited for Further Investigation

CUHK Research Indicates Acupuncture can Improve Cognitive Functions of Elderly - More Elderly Participants to be Recruited for Further Investigation

Research
CUHK Research Reveals that Physical and Cognitive Activities can Maintain and Improve Brain Functions of Patients with Mild Cognitive Impairments

CUHK Research Reveals that Physical and Cognitive Activities can Maintain and Improve Brain Functions of Patients with Mild Cognitive Impairments

Research
CUHK Launches Territory-wide Sleep Health Education Campaign to Promote Healthy Sleep and Healthy School Life

CUHK Launches Territory-wide Sleep Health Education Campaign to Promote Healthy Sleep and Healthy School Life

Health Campaign

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.